Acorda Therapeutics Inc (NASDAQ:ACOR)

33.84
Delayed Data
As of Feb 27
 -1.72 / -4.84%
Today’s Change
28.26
Today|||52-Week Range
45.45
-17.20%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 42.41, with a high estimate of 65.00 and a low estimate of 30.00. The median estimate represents a +25.34% increase from the last price of 33.84.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$101.9M
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1,003.00%
 
 
 
 
 
 
Growthannually -170.80%
 
 
 
 
 
 

Sales

Growthquarterly -13.57%
 
 
 
 
 
 
Growthannually 13.17%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account